Market News Archive

Stay updated with the latest announcements

29 Jan 2025

SEAPEARL: Credit Rating Result

ARGUS Credit Rating Services Limited (ACRSL) has rated the Company as "A" in the long term and "ST-2" in the short term along with Stable outlook based on the audited financial statements up to June 30, 2023 and unaudited financial statements up to the period ended March 31, 2024 and other relevant quantitative as well as qualitative information up to the date of rating declaration.

29 Jan 2025

BATBC: Board Meeting schedule under LR 19(1)

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on February 05, 2025 at 7:00 PM to consider, among others, audited financial statements of the Company for the year ended December 31, 2024.

29 Jan 2025

BXPHARMA: Q2 Financials

(Q2 Un-audited): Consolidated EPS was Tk. 4.10 for October-December 2024 as against Tk. 3.21 for October-December 2023; Consolidated EPS was Tk. 7.87 for July-December 2024 as against Tk. 6.69 for July-December 2023. Consolidated NOCFPS was Tk. 6.13 for July-December 2024 as against Tk. 10.01 for July-December 2023. Consolidated NAV per share was Tk. 111.35 as on December 31, 2024 and Tk. 101.11 as on December 31, 2023.

29 Jan 2025

FORTUNE: Q2 Financials

(Q2 Un-audited): EPS was Tk. 0.09 for October-December 2024 as against Tk. 0.94 for October-December 2023; EPS was Tk. 0.20 for July-December 2024 as against Tk. 1.14 for July-December 2023. NOCFPS was Tk. 0.56 for July-December 2024 as against Tk. 0.50 for July-December 2023. NAV per share was Tk. 13.70 as on December 31, 2024 and Tk. 13.58 as on June 30, 2024.

29 Jan 2025

QUEENSOUTH: Q2 Financials

(Q2 Un-audited): EPS was Tk. 0.11 for October-December 2024 as against Tk. 0.05 for October-December 2023; EPS was Tk. 0.19 for July-December 2024 as against Tk. 0.12 for July-December 2023. NOCFPS was Tk. 1.80 for July-December 2024 as against Tk. (1.13) for July-December 2023. NAV per share was Tk. 15.81 as on December 31, 2024 and Tk. 15.71 as on June 30, 2024.

29 Jan 2025

AZIZPIPES: Q2 Financials

(Q2 Un-audited): EPS was Tk. (0.86) for October-December 2024 as against Tk. (1.58) for October-December 2023; EPS was Tk. (1.68) for July-December 2024 as against Tk. (2.59) for July-December 2023. NOCFPS was Tk. (0.27) for July-December 2024 as against Tk. 0.35 for July-December 2023. NAV per share was Tk. (38.94) as on December 31, 2024 and Tk. (37.28) as on June 30, 2024. (cont.)

29 Jan 2025

RENWICKJA: Q2 Financials

(Q2 Un-audited): EPS was Tk. (5.67) for October-December 2024 as against Tk. (6.60) for October-December 2023; EPS was Tk. (7.56) for July-December 2024 as against Tk. (14.90) for July-December 2023. NOCFPS was Tk. (0.81) for July-December 2024 as against Tk. 0.03 for July-December 2023. NAV per share was Tk. (107.89) as on December 31, 2024 and Tk. (102.83) as on June 30, 2024. (cont.)

29 Jan 2025

SONARGAON: Q2 Financials

(Q2 Un-audited): EPS was Tk. (0.23) for October-December 2024 as against Tk. (0.17) for October-December 2023; EPS was Tk. (0.21) for July-December 2024 as against Tk. (0.25) for July-December 2023. NOCFPS was Tk. 0.025 for July-December 2024 as against Tk. 0.028 for July-December 2023. NAV per share was Tk. 19.11 as on December 31, 2024 and Tk. 19.31 as on June 30, 2024. Reasons for deviation in NOCFPS and NAVPS: (cont.)

29 Jan 2025

ARGONDENIM: Q2 Financials

(Q2 Un-audited): EPS was Tk. 0.57 for October-December 2024 as against Tk. 0.14 for October-December 2023; EPS was Tk. 1.02 for July-December 2024 as against Tk. 0.43 for July-December 2023. NOCFPS was Tk. 1.94 for July-December 2024 as against Tk. 2.59 for July-December 2023. NAV per share was Tk. 24.91 as on December 31, 2024 and Tk. 23.89 as on June 30, 2024.

29 Jan 2025

OAL: Q2 Financials

(Q2 Un-audited): EPS was Tk. (0.18) for October-December 2024 as against Tk. (0.27) for October-December 2023; EPS was Tk. (0.35) for July-December 2024 as against Tk. (0.36) for July-December 2023. NOCFPS was Tk. 0.04 for July-December 2024 as against Tk. (0.04) for July-December 2023. NAV per share was Tk. 9.89 as on December 31, 2024 and Tk. 10.25 as on June 30, 2024.

29 Jan 2025

SEMLIBBLSF: Q2 Financials

(Q2 Un-audited): EPU was Tk. (0.23) for October-December 2024 as against Tk. 0.11 for October-December 2023; EPU was Tk. 0.39 for July-December 2024 as against Tk. 0.13 for July-December 2023. NOCFPU was Tk. 0.37 for July-December 2024 as against Tk. 0.14 for July-December 2023. NAV per unit at market price (Fair Value) was Tk. 9.78 as on December 31, 2024 and Tk. 9.38 as on June 30, 2024. NAV per unit at cost price was Tk. 11.28 as on December 31, 2024 and Tk. 10.89 as on June 30, 2024.

29 Jan 2025

PHARMAID: Q2 Financials

(Q2 Un-audited): EPS was Tk. 5.66 for October-December 2024 as against Tk. 7.21 for October-December 2023; EPS was Tk. 11.32 for July-December 2024 as against Tk. 10.90 for July-December 2023. NOCFPS was Tk. 4.93 for July-December 2024 as against Tk. 10.17 for July-December 2023. NAV per share was Tk. 129.50 as on December 31, 2024 and Tk. 109.89 as on June 30, 2024.

29 Jan 2025

EASTRNLUB: Q2 Financials

(Q2 Un-audited): EPS was Tk. 11.46 for October-December 2024 as against Tk. 3.30 for October-December 2023; EPS was Tk. 17.59 for July-December 2024 as against Tk. 5.47 for July-December 2023. NOCFPS was Tk. 81.72 for July-December 2024 as against Tk. 20.66 for July-December 2023. NAV per share was Tk. 208.46 as on December 31, 2024 and Tk. 190.87 as on June 30, 2024. EPS has been increased due to increase in revenue and non-operating income.

29 Jan 2025

DACCADYE: Q2 Financials

(Q2 Un-audited): EPS was Tk. (1.65) for October-December 2024 as against Tk. (0.21) for October-December 2023; EPS was Tk. (2.09) for July-December 2024 as against Tk. (0.63) for July-December 2023. NOCFPS was Tk. 0.20302 for July-December 2024 as against Tk. 0.39829 for July-December 2023. NAV per share was Tk. 29.45 as on December 31, 2024 and Tk. 31.51 as on June 30, 2024. Significant profit decreases in the 2nd quarter (Q2) period ended 31st Dec., 2024 (cont.)

29 Jan 2025

DULAMIACOT: Q2 Financials

(Q2 Un-audited): EPS was Tk. 0.02 for October-December 2024 as against Tk. (0.14) for October-December 2023; EPS was Tk. 0.23 for July-December 2024 as against Tk. (0.40) for July-December 2023. NOCFPS was Tk. 0.37 for July-December 2024 as against Tk. (0.27) for July-December 2023. NAV per share was Tk. (39.87) as on December 31, 2024 and Tk. (40.08) as on June 30, 2024.

28 Jan 2025
EXCH

DSE NEWS: Daily Turnover of Main Board

Today's (28.01.2025) Total Trades: 123,320; Volume: 124,853,520 and Turnover: Tk. 3,283.188 million.

28 Jan 2025

ICB: Dividend Disbursement

The Company has informed that it has disbursed the Cash Dividend for the year ended June 30, 2024 to the respective shareholders.

28 Jan 2025

HAKKANIPUL: Dividend Disbursement

The Company has informed that it has disbursed the Cash Dividend for the year ended June 30, 2024 to the respective shareholders.

28 Jan 2025

DESHBANDHU: Dividend Disbursement

The Company has informed that it has disbursed the Cash Dividend for the year ended June 30, 2024 to the respective shareholders.

28 Jan 2025

SIPLC: Board Meeting schedule under LR 19(1)

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on February 05, 2025 at 2:45 PM to consider, among others, audited financial statements of the Company for the year ended December 31, 2024.

Latest Price
Quick
AI Desk
Login